The ligase chain reaction in DNA-based diagnosis

Area of Science:

• Molecular Biology
• Diagnostic Microbiology
• Biotechnology

Background:

• Clinical specimens frequently contain insufficient pathogen DNA for direct detection.
• DNA amplification is a prerequisite for accurate pathogen identification in low-biomass samples.
• Existing amplification methods may have limitations in sensitivity, specificity, or require radioactive detection.

Framework:

• The Ligase Chain Reaction (LCR) is presented as a novel DNA amplification technique.
• LCR utilizes enzymatic ligation of sequence-specific oligonucleotide probes to amplify target DNA sequences.
• The method is designed for high specificity and sensitivity in detecting minute amounts of nucleic acids.

Implementation:

• An automated, non-radioactive readout format was developed for LCR detection.
• The system allows for the detection of fewer than 10 molecules of target DNA.
• Prototype assays for Human Immunodeficiency Virus (HIV) and Chlamydia were developed using the LCR platform.

Implications:

• The LCR assay demonstrates sensitivities and specificities equivalent to the established Polymerase Chain Reaction (PCR) method.
• This technology offers a sensitive and specific alternative for pathogen detection in clinical diagnostics.
• The non-radioactive and automated nature of LCR facilitates widespread clinical adoption and reduces laboratory hazards.